Lataa...
Co-occurring genomic alterations in non-small cell lung cancer biology and therapy
The impressive clinical activity of small molecule receptor tyrosine kinase inhibitors (TKIs) for oncogene-addicted subgroups of non-small cell lung cancer (NSCLC) [for example those driven by activating mutations in the gene encoding epidermal growth factor receptor (EGFR) or rearrangements in the...
Tallennettuna:
| Julkaisussa: | Nat Rev Cancer |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7043073/ https://ncbi.nlm.nih.gov/pubmed/31406302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41568-019-0179-8 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|